Not yet recruiting |
: Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS)_MITO 26
: - Carcinosarcoma, Ovarian
- Carcinosarcomas Uterine
: 2016-12-01
: Drug: Trabectedin Other Name: Yondelis
|
Not yet recruiting |
: Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer
: - Advanced Ovarian Carcinoma
- Primary Peritoneal Carcinoma
: 2007-08-03
: Drug: Avastin Initial Treatment:
|
Not yet recruiting |
: Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer
: - Ovarian Carcinosarcoma
- Recurrent Fallopian Tube Carcinoma
: 2009-08-06
: - Drug: Paclitaxel Given IV
|
Recruiting |
: Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
: - Ovarian Brenner Tumor
- Ovarian Carcinosarcoma
-
- Drug: Gemcitabine Hydrochloride
|
Completed |
: Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
: - Fallopian Tube Cancer
- Female Reproductive Cancer
-
: 2006-10-18
: Drug: ziv-aflibercept Given IV Other Names:
|
Completed |
: Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)
: - Brenner Tumor
- Fallopian Tube Cancer
: 2004-06-10
: - Drug: carboplatin Given intrap
|
Active, not recruiting |
: Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy
: - Cognitive Side Effects of Cancer Therapy
- Malignant Ovarian Epithelial Tumor
-
- Procedure: Cognitive Assessment
|
Completed |
: Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer
: - Fallopian Tube Carcinoma
- Infectious Disorder
- Neutropenia
: 2006-07-13
: - Procedure: Adjuvant Therapy
- Drug: Carbopla
|
Recruiting |
: Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery or Gynecological Cancers
: - Cervical Adenosarcoma
- Cervical Adenosquamous Carcinoma
- Cer
: 2013-12-19
: - Biological: Bevacizumab Given
|
Active, not recruiting |
: Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer
: - Adult Hepatocellular Carcinoma
- Advanced Adult Hepatocellular Carcinoma
-
- Biological: Bevacizumab Given
|